Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Noel Milpied"'
Autor:
John A. Snowden, Nicole M. A. Blijlevens, Gloria Tridello, Liesbeth C. de Wreede, Jean-Yves Cahn, Eric Deconinck, Johan Maertens, William Arcese, Malgorzata Mikulska, Jan Styczyński, Patrice Chevallier, Murray Martin, Jan J. Cornelissen, Didier Blaise, Nina Knelange, Rafael de la Cámara, Mahmoud Aljurf, Margherita Mauro, Tsila Zuckerman, Aliénor Xhaard, Noel Milpied, Diana Averbuch, Tobias Gedde-Dahl, Jennifer Byrne, Simone Cesaro, Bruno Lioure, Eefke Petersen, Per Ljungman, Ram Malladi
Publikováno v:
Bone Marrow Transplantation, 56(7), 1563-1572. SPRINGERNATURE
Bone Marrow Transplantation, 56, 7, pp. 1563-1572
Bone Marrow Transplantation, 56, 1563-1572
Bone Marrow Transplantation, 56, 7, pp. 1563-1572
Bone Marrow Transplantation, 56, 1563-1572
Item does not contain fulltext We assessed the incidence and outcome of early candidemia after hematopoietic stem cell transplant (HSCT). The analysis included all first HSCTs performed from 2000 to 2015 in adult and pediatric patients with a non-leu
Autor:
Noel Milpied, Martin Dreyling
Publikováno v:
The EBMT/EHA CAR-T Cell Handbook ISBN: 9783030943523
Mantle cell lymphoma is a distinct lymphoma subtype with a widely varying clinical course. Established high-risk biological factors include blastoid cytomorphology, high cell proliferation (Ki-67 > 67%), and p53 mutations (Aukema et al. 2018). While
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f93d947d472761307d61381928d3541b
https://doi.org/10.1007/978-3-030-94353-0_13
https://doi.org/10.1007/978-3-030-94353-0_13
Autor:
Jan Styczynski, Gloria Tridello, Lidia Gil, Per Ljungman, Malgorzata Mikulska, Steffie van der Werf, Nina Simone Knelange, Diana Averbuch, Gerard Socié, Hendrik Veelken, Jean-Hugues Dalle, Mahmoud Aljurf, Alphan Kupesiz, Yves Bertrand, Abdelghani Tbakhi, Boris Afanasyev, Bruno Lioure, Hélène Labussière-Wallet, Xavier Poiré, Johan Maertens, Eefke Petersen, Patrice Chevallier, Noel Milpied, John A. Snowden, Ibrahim Yakoub-Agha, Jan Cornelissen, Nicolaas Schaap, Carlo Dufour, Regis Peffault de Latour, Arjan Lankester, Simone Cesaro
Publikováno v:
Acta Haematologica Polonica. 51:73-80
BackgroundIn patients with acute leukemia, lymphoma and chronic malignancies, donor and/or recipient Epstein-Barr virus (EBV) seropositive status increases the risk of development of chronic graft-versus-host disease (cGVHD) after allo-hematopoietic
Autor:
Dietrich W. Beelen, Arnon Nagler, Riitta Niittyvuopio, Yngvar Fløisand, Mahmoud Aljurf, Jurjen Versluis, Frédéric Baron, Zinaida Peric, Ali Bazarbachi, Charles Craddock, Fabio Ciceri, Anne Huynh, Francesco Lanza, Arnold Ganser, Maria H. Gilleece, Annalisa Ruggeri, Gesine Bug, Eolia Brissot, Norbert Claude Gorin, Mohamad Mohty, Uwe Platzbecker, Jan J. Cornelissen, Myriam Labopin, Florent Malard, J. Sanz, Sebastian Giebel, Didier Blaise, Roni Shouval, Laimonas Griskevicius, Gérard Socié, Jordi Esteve, Noel Milpied, Bipin N. Savani, Christoph Schmid, Alexandros Spyridonidis
Publikováno v:
Bone Marrow Transplantation, 55(6), 1114-1125. Nature Publishing Group
BONE MARROW TRANSPLANTATION
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
BONE MARROW TRANSPLANTATION
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
To address limitations of the currently used reduced-intensity/myeloablative conditioning (RIC/MAC) classification scheme we aimed to develop a tool that can capture more standardized the conditioning intensity of allogeneic hematopoietic cell transp
Autor:
Martin Wilhelm, Bettina Altmann, Mathieu Leclerc, Laurence de Leval, Ulrich Keller, Arnaud Jaccard, Emmanuel Gyan, Olivier Tournilhac, Peter Reimer, Maike Nickelsen, Martin Dreyling, Jacques-Olivier Bay, Karin Bilger, Bernd Metzner, Andreas Viardot, Laurence Sanhes, Murielle Roussel, Philippe Gaulard, Marita Ziepert, Noel Milpied, Gandhi Damaj, Norbert Schmitz, Friederike Braulke, Walter Lindemann, Eva Maria Wagner-Drouet, Alain Delmer, Bertram Glass, Guillaume Cartron, Thierry Lamy, Krimo Bouabdallah, Viola Poeschel, Frank Kroschinsky, Birte Friedrichs, Lorenz Truemper, David Sibon, Peter Dreger, Andreas Rosenwald, Christian Gisselbrecht, Mathias Haenel, Anne Banos, Gerald Wulf
Publikováno v:
Blood
Blood, American Society of Hematology, 2021, ⟨10.1182/blood.2020008825⟩
Blood, 2021, 2020008825, ⟨10.1182/blood.2020008825⟩
Blood, American Society of Hematology, 2021, 2020008825, ⟨10.1182/blood.2020008825⟩
Blood, American Society of Hematology, 2021, ⟨10.1182/blood.2020008825⟩
Blood, 2021, 2020008825, ⟨10.1182/blood.2020008825⟩
Blood, American Society of Hematology, 2021, 2020008825, ⟨10.1182/blood.2020008825⟩
Standard first-line therapy for younger patients with peripheral T-cell lymphoma consists of six courses of CHOP or CHOEP consolidated by high-dose therapy and autologous stem cell transplantation (AutoSCT). We hypothesized that consolidative allogen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0f0e031c9b11d1bf5b292dc0c3843d1
https://hal.umontpellier.fr/hal-03163608/document
https://hal.umontpellier.fr/hal-03163608/document
Autor:
Grzegorz W. Basak, Boris V. Afanasyev, Péter Reményi, Noel Milpied, Paolo Corradini, Madan Jagasia, Olaf Penack, Henrik Sengeloev, Frank Kroschinsky, Zinaida Peric, Ibrahim Yakoub-Agha, Rafael F. Duarte, Dietger Niederwieser, Edward Kanfer, Steffie van der Werf, Fabio Ciceri, Alessandro Rambaldi, Didier Blaise, Patrice Chevallier, Carlos Solano, Hildegard Greinix, Eric Beohou, Luca Castagna, Nicolaus Kröger, Hélène Schoemans, Agnieszka Tomaszewska, Christian Koenecke, Jean Bourhis, Benedetto Bruno, Christof Scheid, Marco Ladetto, Gérard Socié
Publikováno v:
Frontiers in Immunology
Tomaszewska, A, Jagasia, M, Beohou, E, van der Werf, S, Blaise, D, Kanfer, E, Milpied, N, Reményi, P, Ciceri, F, Bourhis, J H, Chevallier, P, Solano, C, Socié, G, Bruno, B, Rambaldi, A, Castagna, L, Kröger, N, Corradini, P, Afanasyev, B, Ladetto, M, Niederwieser, D, Scheid, C, Sengeloev, H, Kroschinsky, F, Yakoub-Agha, I, Schoemans, H, Koenecke, C, Penack, O, Perić, Z, Greinix, H, Duarte, R F & Basak, G W 2021, ' Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes : EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies ', Frontiers in Immunology, vol. 11, 613954 . https://doi.org/10.3389/fimmu.2020.613954
Frontiers in Immunology, Vol 11 (2021)
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Tomaszewska, A, Jagasia, M, Beohou, E, van der Werf, S, Blaise, D, Kanfer, E, Milpied, N, Reményi, P, Ciceri, F, Bourhis, J H, Chevallier, P, Solano, C, Socié, G, Bruno, B, Rambaldi, A, Castagna, L, Kröger, N, Corradini, P, Afanasyev, B, Ladetto, M, Niederwieser, D, Scheid, C, Sengeloev, H, Kroschinsky, F, Yakoub-Agha, I, Schoemans, H, Koenecke, C, Penack, O, Perić, Z, Greinix, H, Duarte, R F & Basak, G W 2021, ' Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes : EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies ', Frontiers in Immunology, vol. 11, 613954 . https://doi.org/10.3389/fimmu.2020.613954
Frontiers in Immunology, Vol 11 (2021)
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Rituximab (R) is increasingly incorporated in reduced intensity conditioning (RIC) regimens for allogeneic hematopoietic cell transplantation (alloHCT) in patients with B-cell malignancies, not only to improve disease control, but also to prevent gra
Autor:
Krimo Bouabdallah, Lucie Meynard, Francois-Xavier Gros, Mathieu Sauvezie, Noel Milpied, Jean Galtier, Sophie Dimicoli, Marie-Sarah Dilhuydy, Axelle Lascaux, Simon Favre, Lucile Debus
Publikováno v:
Leukemialymphoma. 61(13)
Elderly Hodgkin’s Lymphoma (HL), defined as occurring in patients over 60 years, represents 20% of all Hodgkin’s lymphoma cases and differ from younger HL in clinical, biological, pathological and ...
Autor:
David B. Miklos, Henry C. Fung, Samantha Jaglowski, Lianqing Zheng, Amer Beitinjaneh, Arati V. Rao, Houston Holmes, Max S. Topp, John M. Pagel, Brian T. Hill, Javier Munoz, Roch Houot, Rajul K. Jain, Noel Milpied, Marie José Kersten, Weimin Peng, Caron A. Jacobson, Michael Wang, John M. Rossi, Frederick L. Locke, Patrick M. Reagan, Ian W. Flinn, John M. Timmerman, Peter A. McSweeney, Andre Goy
Publikováno v:
New England journal of medicine, 382(14), 1331-1342. Massachussetts Medical Society
BACKGROUND Patients with relapsed or refractory mantle-cell lymphoma who have disease progression during or after the receipt of Bruton's tyrosine kinase (BTK) inhibitor therapy have a poor prognosis. KTE-X19, an anti-CD19 chimeric antigen receptor (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d56c829bd9f29c06272c5324d0d65d4
https://pure.amc.nl/en/publications/ktex19-car-tcell-therapy-in-relapsed-or-refractory-mantlecell-lymphoma(76a755ff-3b96-4fb9-9a96-4659ea974031).html
https://pure.amc.nl/en/publications/ktex19-car-tcell-therapy-in-relapsed-or-refractory-mantlecell-lymphoma(76a755ff-3b96-4fb9-9a96-4659ea974031).html
Autor:
Mauricette Michallet, Mathilde Hunault-Berger, Nicolaus Kröger, Jörg Cammenga, Johan Maertens, Monique C. Minnema, Jakob Passweg, Joan Hendrik Veelken, Riitta Niittyvuopio, Anja van Biezen, Stefan Schönland, Francisco José Márquez-Malaver, Simona Iacobelli, Arancha Bermúdez, Stéphanie Nguyen, Didier Blaise, Dietger Niederwieser, Ibrahim Yakoub-Agha, Noel Milpied, Patrick Hayden, Laurent Garderet, Yves Chalandon, Ellen Meijer, José Antonio Pérez-Simón, Jean Bourhis
Publikováno v:
Hayden, P J, Iacobelli, S, Pérez-Simón, J A, van Biezen, A, Minnema, M, Niittyvuopio, R, Schönland, S, Meijer, E, Blaise, D, Milpied, N, Márquez-Malaver, F J, Veelken, J H, Maertens, J, Michallet, M, Cammenga, J R, N'Guyen, S, Niederwieser, D, Hunault-Berger, M, Bourhis, J H, Passweg, J, Bermudez, A, Chalandon, Y, Yakoub-Agha, I, Garderet, L & Kröger, N 2020, ' Conditioning-based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991-2012) on behalf of EBMT CMWP ', European Journal of Haematology, vol. 104, no. 3, pp. 181-189 . https://doi.org/10.1111/ejh.13352
European Journal of Haematology
European Journal of Haematology, 2020, 104 (3), pp.181-189. ⟨10.1111/ejh.13352⟩
Digital.CSIC. Repositorio Institucional del CSIC
instname
European Journal of Haematology, 104(3), 181-189. Wiley-Blackwell
European Journal of Haematology, 104(3), 181. Wiley-Blackwell
European Journal of Haematology, Vol. 104, No 3 (2020) pp. 181-189
European Journal of Haematology, Wiley, 2020, 104 (3), pp.181-189. ⟨10.1111/ejh.13352⟩
European Journal of Haematology. WILEY
European Journal of Haematology
European Journal of Haematology, 2020, 104 (3), pp.181-189. ⟨10.1111/ejh.13352⟩
Digital.CSIC. Repositorio Institucional del CSIC
instname
European Journal of Haematology, 104(3), 181-189. Wiley-Blackwell
European Journal of Haematology, 104(3), 181. Wiley-Blackwell
European Journal of Haematology, Vol. 104, No 3 (2020) pp. 181-189
European Journal of Haematology, Wiley, 2020, 104 (3), pp.181-189. ⟨10.1111/ejh.13352⟩
European Journal of Haematology. WILEY
[Objectives] The aim of this study was to compare the effect of the intensity of conditioning approaches used in allogeneic transplantation in myeloma—reduced intensity conditioning (RIC), non‐myeloablative (NMA), myeloablative conditioning (MAC)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::465bcde0e81b55721a1f57e75c6e69cf
https://research.vumc.nl/en/publications/bcb5e8f0-4a5a-40fc-b72c-81940d8276fc
https://research.vumc.nl/en/publications/bcb5e8f0-4a5a-40fc-b72c-81940d8276fc
Autor:
Karin Tarte, Thomas E. Witzig, Imane Azzaoui, Thomas M. Habermann, Andrew L. Feldman, Céline Pangault, Noel Milpied, Stephen M. Ansell, Thierry Fest, Marie Parrens, Matthew J. Maurer, James R. Cerhan, Delphine Rossille, Mikael Roussel, Susan L. Slager, Thierry Lamy, Gaëlle Labouré, Brian K. Link
Publikováno v:
Leukemia
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2017, 31 (4), pp.988-991. ⟨10.1038/leu.2016.385⟩
Leukemia, 2017, 31 (4), pp.988-991. ⟨10.1038/leu.2016.385⟩
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2017, 31 (4), pp.988-991. ⟨10.1038/leu.2016.385⟩
Leukemia, 2017, 31 (4), pp.988-991. ⟨10.1038/leu.2016.385⟩
Diffuse large B-cell lymphoma (DLBCL) is an aggressive hematologic malignancy with more than two-thirds of the patients cured with first-line rituximab-based treatments. However, relapsing or refractory patients have a very poor survival despite salv